Nationwide registration and clinical evaluation of the heavy particle beam therapy studies.

Nationwide registration and clinical evaluation of the heavy particle beam therapy studies. - Nationwide registration and clinical evaluation of the heavy particle beam therapy studies.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024709

Enrollment

30000

Registered

2016-11-04

Start date

2016-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Lung Esophagus Lower gastrointestinal tract Hepato-biliary-pancreatic Urinary organ mammary-uterine-cervix Bone and Soft tissue Metastatic disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All cases receiving heavy particle radiation therapy in each collaborative research institute will be covered from 1 May 2016 to 31 March 2026.

Exclusion criteria

Exclusion criteria: If patients or their families refuse to provide materials for this research, they are excluded.

Design outcomes

Primary

Measure	Time frame
survival rate	—

Secondary

Measure	Time frame
Local control period Progression-free survival Adverse event Evaluation of Quality of Life	—

Countries

Japan

Contacts

Public ContactKensuke Umehara

National Institutes for Quantum Science and Technology QST Hospital

umehara.kensuke@qst.go.jp043-206-4630

Outcome results